• LY2886721: Navigating BACE1 Inhibition Thresholds in Alzheim

  2026-05-09

  Explore how LY2886721, a potent BACE inhibitor, advances Alzheimer's disease research by enabling precise amyloid beta reduction without compromising synaptic function. This article uniquely analyzes synaptic safety thresholds and translational assay decisions using the latest peer-reviewed findings.

• Ferritin Hybrid Protein Particle Vaccine: M2e and SARS-CoV-2

  2026-05-08

  This study introduces a ferritin-based hybrid protein particle vaccine that co-displays antigens from influenza A (M2e) and SARS-CoV-2 S-protein tandem epitopes. The approach leverages E. coli expression and ferritin self-assembly to enhance immunogenicity, offering a platform for next-generation combination vaccines and informing immunoassay development.

• Ruxolitinib Triggers Apoptosis in ATC by Targeting Mitochond

  2026-05-08

  This study reveals that ruxolitinib, a JAK1/2 inhibitor, induces both apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) cells by transcriptionally suppressing DRP1-mediated mitochondrial fission. The results highlight a novel mechanistic link between JAK1/2-STAT3-DRP1 signaling and mitochondrial integrity, offering new therapeutic perspectives for highly aggressive ATC.

• NHS-Biotin (A8002): Redefining Protein Multimerization Preci

  2026-05-07

  Explore how NHS-Biotin enables next-generation, amine-specific biotinylation for protein multimerization and detection. This article reveals unique mechanistic insights, advanced intracellular applications, and practical guidance distinct from current literature.

• γH2AX DNA Damage Detection: Mechanism, Impact, and Strategy

  2026-05-07

  This thought-leadership article examines the mechanistic, experimental, and translational dimensions of γH2AX as a DNA damage biomarker. Drawing on recent advances in radioimmunotherapy, it demonstrates how APExBIO’s γH2AX DNA Damage Detection Kit (Mouse mAb/Red) empowers researchers to bridge mechanistic inquiry with clinical innovation. The discussion contextualizes best practices, protocol design, and emerging strategic opportunities for translational research, highlighting actionable guidance and future outlook.

• Dorsomorphin (Compound C): Optimizing AMPK and BMP Assays

  2026-05-06

  Dorsomorphin (Compound C) uniquely empowers targeted AMPK and BMP pathway modulation across metabolic and differentiation assays. This guide provides actionable workflows, troubleshooting strategies, and innovative protocol enhancements, informed by recent research and validated use-cases.

• Capecitabine in Advanced Assembloid Models: Protocols & Insi

  2026-05-06

  Capecitabine (N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine) enables precise, tumor-selective cytotoxicity studies in complex preclinical models. This guide translates the latest assembloid methodologies and APExBIO’s reagent quality into actionable protocols and troubleshooting tips for high-impact oncology research.

• 5-Methyl-CTP: Optimizing mRNA Synthesis and Vaccine Platform

  2026-05-05

  Leverage 5-Methyl-CTP for enhanced mRNA stability and translation efficiency in both therapeutic research and cutting-edge vaccine delivery systems. This article delivers actionable workflows, protocol parameters, and troubleshooting guidance, empowering scientists to accelerate mRNA-based drug development with confidence.

• SIS3 (Smad3 Inhibitor): Unraveling TGF-β Pathway Control in

  2026-05-05

  Explore the latest scientific advances on SIS3, a potent Smad3 inhibitor, and its unique mechanistic and translational value in TGF-β pathway research. Discover how new evidence from osteoarthritis models informs practical assay choices in fibrosis and renal disease studies.

• Exemestane: Steroidal Aromatase Inhibitor in Breast Cancer R

  2026-05-04

  Unlock robust, reproducible estrogen biosynthesis inhibition in hormone-dependent cancer research with Exemestane from APExBIO. This guide details optimized experimental workflows, advanced use-cases, and proven troubleshooting strategies to maximize assay reliability and translational impact.

• Super-Enhancer Hijacking of LINC01977 Drives Early LUAD Mali

  2026-05-04

  Zhang et al. (2022) illuminate how super-enhancer-mediated upregulation of lncRNA LINC01977 promotes malignancy in early-stage lung adenocarcinoma (LUAD) through the canonical TGF-β/SMAD3 pathway. This study provides mechanistic insight into epigenetic drivers of LUAD progression and offers potential targets for future cancer biology research.

• Sodium Picosulfate: Applied Workflows for Constipation Model

  2026-05-03

  Sodium Picosulfate enables robust, reproducible modeling of chronic and opioid-induced constipation for gut–liver–brain axis research. This guide details stepwise workflows, troubleshooting, and actionable protocol enhancements for advanced gastrointestinal and cell-based assays, leveraging APExBIO’s high-purity standard.

• Pomalidomide (CC-4047): Precision Tools for Modeling Tumor H

  2026-05-02

  Explore how Pomalidomide (CC-4047) empowers researchers to dissect tumor heterogeneity and drug resistance in hematological malignancy research. This article uniquely bridges molecular mechanism with experimental strategy, grounded in cutting-edge mutational landscape analysis.

• CX-4945 (Silmitasertib): Reliable CK2 Inhibition in Lab Assa

  2026-05-02

  This in-depth guide addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how CX-4945 (Silmitasertib, SKU A8330) provides robust, reproducible CK2 inhibition. Drawing on recent literature and real-world scenarios, it details protocol optimization, data interpretation, and product selection strategies to ensure confident experimental outcomes.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-05-01

  This study reveals that yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) through separate signaling mechanisms. The findings clarify pathogen-specific cell death processes, informing future research on mastitis pathogenesis and potential intervention strategies.

15653 records 1/1044 page Next 12345 下5页 Last page